Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML)

Clinical trial NCT01550224 · COMPLETED

Trial details

NCT number: NCT01550224
Sponsor: Steven E. Coutre
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia With 11q23-abnormality in Relapse

Start date: 2013-05-01
Primary completion: 2014-11-17
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.